NK immunotherapy

BIOLOGICAL18 trials

Sponsors

Fuda Cancer Hospital, Guangzhou

Conditions

B-cell Lymphoma RecurrentBreast Cancer RecurrentEvidence of Liver TransplantationLiver TumorMalignant Solid TumourMetastatic Esophageal CancerMetastatic Renal Cell CancerNon-small Cell Lung Cancer Metastatic

Phase 1

Combination of Rituximab and NK Immunotherapy for B Lymphoma

CompletedNCT02843061

Fuda Cancer Hospital, GuangzhouB-cell Lymphoma Recurrent

Start: 2016-07-01End: 2019-07-01Updated: 2019-09-12

Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast Cancer

CompletedNCT02843126

Fuda Cancer Hospital, GuangzhouRecurrent Breast Cancer

Start: 2016-07-01End: 2019-07-01Updated: 2019-09-12

Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid Tumors

CompletedNCT02843204

Fuda Cancer Hospital, GuangzhouMalignant Solid Tumour

Start: 2016-07-01End: 2019-07-01Updated: 2020-05-28

Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer

CompletedNCT02843581

Fuda Cancer Hospital, GuangzhouMetastatic Esophageal Cancer

Start: 2016-07-01End: 2019-07-01Updated: 2019-09-12

Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer

CompletedNCT02843802

Fuda Cancer Hospital, GuangzhouSecondary Malignant Neoplasm of Liver

Start: 2016-07-01End: 2019-07-01Updated: 2019-09-12

Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer

CompletedNCT02843815

Fuda Cancer Hospital, GuangzhouNon-small Cell Lung Cancer Metastatic

Start: 2016-07-01End: 2019-07-01Updated: 2019-09-12

Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer

CompletedNCT02844335

Fuda Cancer Hospital, GuangzhouBreast Cancer Recurrent

Start: 2016-07-01End: 2019-07-01Updated: 2019-09-12

Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer

CompletedNCT02843607

Fuda Cancer Hospital, GuangzhouMetastatic Renal Cell Cancer

Start: 2016-07-01End: 2019-07-01Updated: 2019-09-12

Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer

CompletedNCT02845856

Fuda Cancer Hospital, GuangzhouRecurrent Non-small Cell Lung Cancer

Start: 2016-07-01End: 2019-07-01Updated: 2019-09-12

Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer

CompletedNCT02849340

Fuda Cancer Hospital, GuangzhouRecurrent Cervical Cancer

Start: 2016-07-01End: 2019-07-01Updated: 2019-09-12

Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian Cancer

CompletedNCT02849353

Fuda Cancer Hospital, GuangzhouRecurrent Ovarian Cancer

Start: 2016-07-01End: 2019-07-01Updated: 2019-09-12

Combination of Cryosurgery and NK Immunotherapy for Recurrent Sarcoma

CompletedNCT02849366

Fuda Cancer Hospital, GuangzhouRecurrent Adult Soft Tissue Sarcoma

Start: 2016-07-01End: 2019-07-01Updated: 2019-09-12

Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal Cancer

CompletedNCT02849327

Fuda Cancer Hospital, GuangzhouRecurrent Pharyngeal Cancer

Start: 2016-07-01End: 2019-07-01Updated: 2019-09-12

Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer

CompletedNCT02849314

Fuda Cancer Hospital, GuangzhouRecurrent Laryngeal Cancer

Start: 2016-07-01End: 2019-07-01Updated: 2019-09-12

Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver

CompletedNCT02849015

Fuda Cancer Hospital, GuangzhouEvidence of Liver Transplantation, Liver Tumor

Start: 2016-07-01End: 2018-07-01Updated: 2019-09-12

Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer

CompletedNCT02849379

Fuda Cancer Hospital, GuangzhouRecurrent Tongue Cancer

Start: 2016-07-01End: 2019-07-01Updated: 2019-09-12

Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors

CompletedNCT02857920

Fuda Cancer Hospital, GuangzhouMalignant Solid Tumour

Start: 2016-08-01End: 2019-08-01Updated: 2020-09-14

Phase 2

Comparison of Autogenic and Allogenic NK Immunotherapy on the Outcome of Recurrent Solid Tumors

CompletedNCT02853903

Fuda Cancer Hospital, GuangzhouMalignant Solid Tumour

Start: 2016-07-01End: 2019-07-01Updated: 2019-09-12

Related Papers

Pembrolizumab plus allogeneic NK cells in advanced non–small cell lung cancer patients

Journal of Clinical Investigation2020-02-06132 citations